Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia | Experimental Hematology & Oncology | Full Text
Cancers | Free Full-Text | Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies - Harada - 2015 - Cancer Science - Wiley Online Library
Cancers | Free Full-Text | Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia
A model of MDS formation and progression. It is hypothesized that the... | Download Scientific Diagram
Frontiers | Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia - ScienceDirect
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level | Nature Medicine
What biologic factors predict for transformation to AML? - ScienceDirect
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome | Bone Marrow Transplantation
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management - Garcia‐Manero - 2020 - American Journal of Hematology - Wiley Online Library
Inflammation may predict transformation to AML | MDedge Hematology and Oncology
OS and time to AML progression in MDS patients. OS (A) and time to AML... | Download Scientific Diagram
Myelodysplastic Syndromes: - ppt video online download
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms | Haematologica
Schematic representation of possible MDS/AML development in aplastic... | Download Scientific Diagram
Genetics of progression from MDS to secondary leukemia - ScienceDirect
OS and time to AML progression in MDS patients. OS (A) and time to AML... | Download Scientific Diagram
Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes | Nature Communications
Potential for HSP90 inhibition in MDS and AML. Myelodysplastic... | Download Scientific Diagram
